These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14246605)

  • 1. POLIOVIRUS ANTIBODY TWO YEARS AFTER ORAL TRIVALENT VACCINE (SABIN STRAINS).
    CABASSO VJ; NOZELL H; RUEGSEGGER JM; COX HR
    JAMA; 1964 Oct; 190():248-50. PubMed ID: 14246605
    [No Abstract]   [Full Text] [Related]  

  • 2. PERSISTENCE OF ANTIBODY AFTER ORAL TRIVALENT POLIOVIRUS VACCINE (SABIN STRAINS).
    CABASSO VJ; NOZELL H; RUEGSEGGER JM; COX HR
    N Engl J Med; 1964 Feb; 270():443-6. PubMed ID: 14163223
    [No Abstract]   [Full Text] [Related]  

  • 3. [IMMUNOLOGIC RESPONSE TO THE ORAL ADMINISTRATION OF TRIVALENT VACCINE (SABIN)].
    VILLALOBOSRODAS A; DELPILAROLMOS M
    Salud Publica Mex; 1963; 5():933-6. PubMed ID: 14119839
    [No Abstract]   [Full Text] [Related]  

  • 4. SEROLOGICAL SURVEY OF CHILDREN IN MOSCOW FOR ANTIBODY TO POLIOVIRUSES, 1961 AND 1962.
    VOROSILOVA MK; TARANOVA GP; EMELJANENKOVA VP; SCEGLOVA AP
    Bull World Health Organ; 1965; 32(3):317-29. PubMed ID: 14315707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THE IMMUNIZING EFFECT OF A TWO-DOSE TRIVALENT ORAL POLIO VACCINE.
    CLAYTON LB; FLIPSE ME; HOFFERT WR; CROSSLEY MI
    Curr Ther Res Clin Exp; 1965 Jan; 7():1-6. PubMed ID: 14246364
    [No Abstract]   [Full Text] [Related]  

  • 6. [FIELD TRIAL WITH LIVE ORAL POLIOVIRUS VACCINE. II. PRODUCTION OF NEUTRALIZING ANTIBODIES FOLLOWING THE ADMINISTRATION OF MONOVALENT ORAL POLIOVIRUS VACCINE].
    OGAWA M; KANNO T; URASAWA S
    Sapporo Igaku Zasshi; 1963 Mar; 23():202-9. PubMed ID: 14057343
    [No Abstract]   [Full Text] [Related]  

  • 7. POLIOVIRUS VACCINE, LIVE, ORAL (SABIN). FIRST FIELD TRIAL IN INDIA. II. RESULTS OF LABORATORY TESTS.
    DAVE KH; KAUR B; GHARPURE PV
    Indian J Med Sci; 1964 Jan; 18():1-12. PubMed ID: 14117945
    [No Abstract]   [Full Text] [Related]  

  • 8. A MASS VACCINATION CAMPAIGN AGAINST POLIOMYELITIS USING THE SABIN ORAL VACCINE.
    FRANKLIN GC; ROBERTSON MJ
    Public Health; 1965 Jan; 79():81-99. PubMed ID: 14251614
    [No Abstract]   [Full Text] [Related]  

  • 9. RESPONSE TO ONE DOSE OF TRIVALENT ORAL POLIOVACCINE IN CHILDREN PREVIOUSLY IMMUNISED WITH SALK VACCINE: A COMPARISON OF LIQUID VACCINE AND A CAPSULE PRESENTATION.
    BEALE AJ; DAVIES JR; THROWER AL
    Lancet; 1965 Apr; 1(7391):879-81. PubMed ID: 14272682
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON SABIN VACCINE ADMINISTRATION IN NAGAOKA CITY IN 1960.
    SHIMOJO H; SODA K; NAKANO M; TAGAYA I
    Jpn J Med Sci Biol; 1963 Dec; 16():315-24. PubMed ID: 14130751
    [No Abstract]   [Full Text] [Related]  

  • 11. MASS IMMUNISATION AGAINST POLIOMYELITIS IN CEYLON IN 1962 USING SABIN ORAL VACCINE.
    ARUMANAYAGAM P
    J Trop Med Hyg; 1965 May; 68():105-9. PubMed ID: 14287300
    [No Abstract]   [Full Text] [Related]  

  • 12. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POLIOVIRUS SHEDDING AND SEROCONVERSION. STUDIES OF 816 COSTA RICAN CHILDREN FED TRIVALENT VACCINE.
    ROCA-GARCIA M; MARKHAM FS; COX HR; VARGAS-MENDEZ O; GUEVARA EC; MONTOYA JA
    JAMA; 1964 May; 188():639-46. PubMed ID: 14121285
    [No Abstract]   [Full Text] [Related]  

  • 14. POLIOVIRUS IN FEBRILE VACCINEES.
    KELLY S; FOX JP; SPIGLAND I
    Arch Environ Health; 1965 Jan; 10():16-20. PubMed ID: 14219480
    [No Abstract]   [Full Text] [Related]  

  • 15. THE RESPONSE AND THE LACK OF SPREAD IN SWEDISH SCHOOL CHILDREN GIVEN AN ATTENUATED POLIOVIRUS VACCINE PREPARED IN A HUMAN DIPLOID CELL STRAIN.
    PAGANO JS; BOETTIGER M; BONNEVIER JO; GARD S
    Am J Hyg; 1964 Jan; 79():74-85. PubMed ID: 14114357
    [No Abstract]   [Full Text] [Related]  

  • 16. SALK AND SABIN VACCINATION OF POPULATION GROUPS; AN EPIDEMIOLOGIC EVALUATION.
    TAUBENHAUS LJ; FRECKLETON FR; DONNELLAN EK
    Arch Environ Health; 1964 Jul; 9():37-42. PubMed ID: 14160101
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL AND ELECTROENCEPHALOGRAPHIC FINDINGS ON PSYCHO-ORGANIC MANIFESTATIONS NOTED IN CHILDREN VACCINATED WITH LIVE ATTENUATED SABIN POLIOVIRUS VACCINE].
    LOPERFIDO E; ANCONA A; PIERALISI G
    Clin Pediatr (Bologna); 1964 Jun; 46():SUPPL:89-99. PubMed ID: 14276643
    [No Abstract]   [Full Text] [Related]  

  • 18. [POLIOMYELITIS IN THE CHILD. REFERENCES TO VIROLOGICAL FINDINGS].
    GONZALEZ M; SCROGGIE S; DIAZ R
    Rev Chil Pediatr; 1964 Jan; 35():24-8. PubMed ID: 14163294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Seroconversion with trivalent Sabin vaccine in children less than four years of age].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML
    Bol Med Hosp Infant Mex; 1989 Aug; 46(8):517-25. PubMed ID: 2553055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE EFFECT OF PREVACCINAL IMMUNITY ON VIRAL EXCRETION AND ANTIBODY FORMATION FOLLOWING TYPE I ORAL POLIOVIRUS VACCINATION (SABIN)].
    SIEGERT R; ENDERS-RUCKLE G; OEHME J; WALLER HD
    Dtsch Med Wochenschr; 1963 Aug; 88():1586-94. PubMed ID: 14047334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.